These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12823645)

  • 21. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women.
    Squadrito F; Altavilla D; Morabito N; Crisafulli A; D'Anna R; Corrado F; Ruggeri P; Campo GM; Calapai G; Caputi AP; Squadrito G
    Atherosclerosis; 2002 Aug; 163(2):339-47. PubMed ID: 12052481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjugated equine estrogen, raloxifene and arterial stiffness in postmenopausal women.
    Dias AR; de Mello NR; Eluf Gebara OC; Nussbacher A; Wajngarten M; Petti DA
    Climacteric; 2008 Oct; 11(5):390-6. PubMed ID: 18781483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XbaI polymorphism of the estrogen receptor alpha gene influences the effect of raloxifene on the endothelial function.
    Zavratnik A; Zegura B; Marc J; Prezelj J; Pfeifer M
    Maturitas; 2010 Sep; 67(1):84-90. PubMed ID: 20609538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of raloxifene, one of the selective estrogen receptor modulators, on pituitary-ovary axis and prolactin in postmenopausal women.
    Cheng WC; Yen ML; Hsu SH; Chen KH; Tsai KS
    Endocrine; 2004; 23(2-3):215-8. PubMed ID: 15146102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of different hormone treatment on endothelial function in healthy postmenopausal women.
    Akman L; Duygu H; Akercan F; Ulukus M; Ozerkan F; Akin M
    Gynecol Endocrinol; 2013 Sep; 29(9):867-72. PubMed ID: 23875965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of raloxifene and estrogen on insulin sensitivity in postmenopausal women.
    Lee CC; Kasa-Vubu JZ; Supiano MA
    J Am Geriatr Soc; 2003 May; 51(5):683-8. PubMed ID: 12752845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women.
    Neele SJ; Evertz R; De Valk-De Roo G; Roos JC; Netelenbos JC
    Bone; 2002 Apr; 30(4):599-603. PubMed ID: 11934652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women.
    Blum A; Hathaway L; Mincemoyer R; Schenke WH; Kirby M; Csako G; Waclawiw MA; Panza JA; Cannon RO
    J Am Coll Cardiol; 2000 Feb; 35(2):271-6. PubMed ID: 10676669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.
    de Valk-de Roo GW; Stehouwer CD; Meijer P; Mijatovic V; Kluft C; Kenemans P; Cohen F; Watts S; Netelenbos C
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2993-3000. PubMed ID: 10591680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of raloxifene hydrochloride.
    Saitta A; Morabito N; Frisina N; Cucinotte D; Corrado F; D'Anna R; Altavilla D; Squadrito G; Minutoli L; Arcoraci V; Cancellieri F; Squadrito F
    Cardiovasc Drug Rev; 2001; 19(1):57-74. PubMed ID: 11314601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
    Johnston CC; Bjarnason NH; Cohen FJ; Shah A; Lindsay R; Mitlak BH; Huster W; Draper MW; Harper KD; Heath H; Gennari C; Christiansen C; Arnaud CD; Delmas PD
    Arch Intern Med; 2000 Dec 11-25; 160(22):3444-50. PubMed ID: 11112238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
    Huerta-Ramos E; Labad J; Cobo J; Núñez C; Creus M; García-Parés G; Cuadras D; Franco J; Miquel E; Reyes JC; Marcó-García S; ; Usall J
    Eur Arch Psychiatry Clin Neurosci; 2020 Sep; 270(6):729-737. PubMed ID: 31728631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Papadias C; Sarandakou A; Liakakos T; Alexandrou A; Creatsas G
    Eur J Endocrinol; 2004 Aug; 151(2):187-92. PubMed ID: 15296473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.
    Freedman M; San Martin J; O'Gorman J; Eckert S; Lippman ME; Lo SC; Walls EL; Zeng J
    J Natl Cancer Inst; 2001 Jan; 93(1):51-6. PubMed ID: 11136842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium-a pilot study.
    Davis SR; O'Neill SM; Eden J; Baber R; Ekangaki A; Stocks JM; Thiebaud D
    Menopause; 2004; 11(2):167-75. PubMed ID: 15021446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen.
    Goldstein SR; Johnson S; Watts NB; Ciaccia AV; Elmerick D; Muram D
    Menopause; 2005 Mar; 12(2):160-4. PubMed ID: 15772563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zhu XM; Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Wang XP; Kulkarni J; Grigg J; Ning YP; Xiang YT
    Schizophr Res; 2018 Jul; 197():288-293. PubMed ID: 29395611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.
    Squadrito F; Altavilla D; Crisafulli A; Saitta A; Cucinotta D; Morabito N; D'Anna R; Corrado F; Ruggeri P; Frisina N; Squadrito G
    Am J Med; 2003 Apr; 114(6):470-6. PubMed ID: 12727580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of soy isoflavones on endothelial function in healthy postmenopausal women.
    Colacurci N; Chiàntera A; Fornaro F; de Novellis V; Manzella D; Arciello A; Chiàntera V; Improta L; Paolisso G
    Menopause; 2005; 12(3):299-307. PubMed ID: 15879919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.